POINT Biopharma Global, Inc. is a radiopharmaceutical company. It engages in the business of building a platform for the clinical development and commercialization of radioligands that fight cancer. The company was founded by Joe McCann and Neil E. Fleshner on April 15, 2020 and is headquartered in Indianapolis, IN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of POINT Biopharma Global Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. POINT Biopharma Global Inc market cap is $1.33B.
What is the 52-week high for POINT Biopharma Global Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. POINT Biopharma Global Inc 52 week high is $14.35 as of September 06, 2025.
What is the 52-week low for POINT Biopharma Global Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. POINT Biopharma Global Inc 52 week low is $6.57 as of September 06, 2025.
What is POINT Biopharma Global Inc stock price today?
POINT Biopharma Global Inc stock price today is $12.50.
What was POINT Biopharma Global Inc stock price yesterday?
POINT Biopharma Global Inc stock price yesterday was $12.48.
What is the PE ratio of POINT Biopharma Global Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. POINT Biopharma Global Inc’s P/E ratio is 13.97.
What is the Price-to-Book ratio of POINT Biopharma Global Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. POINT Biopharma Global Inc P/B ratio is 3.1167.
What is POINT Biopharma Global Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. POINT Biopharma Global Inc's EBITDA is 3.42.
What is the 50-day moving average of POINT Biopharma Global Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. POINT Biopharma Global Inc 50-day moving average is $13.19.